T. Rowe Price Investment Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.2M Buy
1,090,947
+196,671
+22% +$7.68M 0.04% 375
2026
Q1
$31.6M Buy
894,276
+892,177
+42,505% +$27.7M 0.02% 417
2025
Q4
$59K Buy
+2,099
New +$62.9K ﹤0.01% 664
2022
Q4
– Sell
-4,562,808
Closed -$102M – 543
2022
Q3
$102M Buy
+4,562,808
New +$119M 0.08% 238

Other funds holding ALKS

T. Rowe Price Investment Management's ALKS Position: Q2 2026 in Review

T. Rowe Price Investment Management increased its Alkermes (ALKS) stake by 22% in Q2 2026, buying an estimated $7.68M and bringing the position to 1,090,947 shares worth $57.2M. The position accounts for 0.04% of the portfolio, ranked #375.

T. Rowe Price Investment Management first reported a position in ALKS in Q3 2022 and has held it in 4 quarters since. The position peaked at $102M in Q3 2022. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • T. Rowe Price Investment Management held 1,090,947 shares of Alkermes worth $57.2M as of Q2 2026.
  • T. Rowe Price Investment Management bought 196,671 Alkermes shares in Q2 2026, an estimated $7.68M.
  • Alkermes made up 0.04% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #375 holding.
  • T. Rowe Price Investment Management first reported a position in Alkermes in Q3 2022 and has held it in 4 quarters since.
  • T. Rowe Price Investment Management's Alkermes position peaked at $102M in Q3 2022.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.